Dr. Samir Saba, MD
Claim this profileUniversity of Pittsburgh Medical Center
Studies Atrial Fibrillation
Studies Heart Attack
4 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Samir Saba, MD is currently running
AI Chatbot Education
for Atrial Fibrillation
Atrial Fibrillation is a chronic disease with significant health consequences like increased risk of stroke, heart failure, heart attack and death. Educating patients about the disease is important for them to be able to understand the condition better, feel empowered and take an active part in their care plan. AI technology can potentially be used to impart such education. However, doing so with care and empathy is equally important. Therefore, it is necessary to ensure when AI technology is used to impart education about atrial fibrillation to patients, the humane aspects of the interaction are rigorously tested. This study examines a way to impart atrial fibrillation education through interaction with an AI chatbot, that uses text and links to educational videos. To participate in this study, people need to be age 18 or older and have a history of newly diagnosed atrial fibrillation. Approximately 40 individuals will be asked to take part in this study. The first step to the study will be reading through, understanding, and signing an informed consent. People who then agree to join the study will have a one-time interaction with the AI chatbot and structured educational material by using an iPad provided to them for the approximately 1 hour duration of the study. People in the study will obtain atrial fibrillation education by typing one by one on the iPad, up to 10 questions about the disease. Answers will include text and links to videos. Before and after atrial fibrillation education, people who join this study will be asked to fill out a survey. The study team will teach patients how to use the iPad and type in questions.
Recruiting1 award N/A2 criteria
ICM Implantation
for Heart Attack
Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.
Recruiting1 award N/A5 criteria
More about Samir Saba, MD
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Samir Saba, MD has experience with
- Atrial Fibrillation Education
- ICM Implantation
- Amplatzer Amulet LAA Occluder
- Non-Vitamin K Oral Antagonists
- WiSE System
Breakdown of trials Samir Saba, MD has run
Atrial Fibrillation
Heart Attack
Myocardial Infarction or Heart Attack
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samir Saba, MD specialize in?
Samir Saba, MD focuses on Atrial Fibrillation and Heart Attack. In particular, much of their work with Atrial Fibrillation has involved treating patients, or patients who are undergoing treatment.
Is Samir Saba, MD currently recruiting for clinical trials?
Yes, Samir Saba, MD is currently recruiting for 3 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Samir Saba, MD has studied deeply?
Yes, Samir Saba, MD has studied treatments such as Atrial Fibrillation Education, ICM Implantation, Amplatzer Amulet LAA Occluder.
What is the best way to schedule an appointment with Samir Saba, MD?
Apply for one of the trials that Samir Saba, MD is conducting.
What is the office address of Samir Saba, MD?
The office of Samir Saba, MD is located at: University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213 United States. This is the address for their practice at the University of Pittsburgh Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.